There is something particularly cruel about sitting in a lecture or staring at a screen full of new material and realising the words simply aren't sticking — when a year earlier they would have. So many women blame themselves, assume they've left it too late, or quietly drop out. The hormones were the problem, not the ambition.
Learn more about Rose →Working memory — the short-term mental workspace used to hold and manipulate new information — depends heavily on oestrogen, which acts on prefrontal cortex receptors involved in attention and cognitive flexibility. As oestrogen levels fluctuate and trend downward in perimenopause, the capacity to retain a sequence of instructions, follow a multi-step argument, or hold a formula in mind while applying it can noticeably shrink. This is not a permanent change for most women; studies tracking cognitive performance across the menopause transition show that working memory largely stabilises post-menopause, but the dip lands squarely in the retraining years for many women in their 40s.
Memory consolidation — the process by which the brain converts newly learned material into stable long-term storage — happens primarily during slow-wave and REM sleep, both of which are disrupted by night sweats, frequent waking, and the sleep architecture changes associated with perimenopause. A student who studies in the evening and then wakes repeatedly overnight is effectively undermining the very process that should be cementing that evening's work. Research consistently shows that even moderate sleep restriction significantly impairs the next day's ability to encode new information, creating a compounding deficit for anyone in active study.
The tip-of-the-tongue phenomenon — knowing a word or concept but being momentarily unable to retrieve it — becomes more frequent during perimenopause and is linked to fluctuating oestrogen levels affecting hippocampal retrieval pathways. In everyday conversation, a brief pause is unremarkable; in an oral exam, a seminar presentation, or a timed written assessment, the same pause carries real academic cost and significant anxiety. Women often catastrophise these moments as signs of early cognitive decline, when in fact the symptom is well-documented, common, and not predictive of dementia.
Perimenopause is associated with a measurable increase in generalised anxiety, partly driven by the effect of fluctuating oestrogen on GABA and serotonin systems, and partly by disrupted sleep compounding stress reactivity. In exam or assessment conditions, elevated baseline anxiety triggers cortisol responses that further suppress hippocampal function — meaning the very environment designed to measure learning actively makes retrieval harder. Women who had no prior history of test anxiety may find it appearing for the first time during perimenopause, and the physiological explanation is straightforward even if it rarely gets named.
A vasomotor episode in a quiet exam hall or classroom is not just physically uncomfortable — the sudden heat, flushing, and sweating demand immediate attentional resources that are then unavailable for the task in front of the woman. The anticipatory anxiety of wondering whether a flush will arrive during a high-stakes moment can itself become a chronic distraction, consuming cognitive bandwidth across an entire course. Vasomotor symptoms are among the most effectively treated perimenopause symptoms, and women sitting exams or attending classes regularly deserve to know that management options exist.
Sustained attention — the ability to stay focused on a single task for an extended period — is regulated in part by dopaminergic and noradrenergic systems that oestrogen modulates. During perimenopause, erratic oestrogen fluctuations rather than a smooth decline appear to cause the most acute cognitive disruption, which is why some women report concentration being worse during perimenopause than it becomes post-menopause when levels have settled. For someone trying to sit through a two-hour lecture, complete an online module, or read dense academic material, even a modest reduction in sustained attention span creates a meaningful barrier.
Perimenopausal fatigue — the kind that follows repeated nights of broken sleep — can be profound enough to make sitting at a desk and engaging with study material feel physically impossible, not just undesirable. Women, and sometimes their tutors or employers, may interpret this as disengagement, laziness, or a sign that the return to education was poorly timed, when the underlying cause is physiological sleep disruption. Identifying the cause matters because fatigue driven by night sweats responds to targeted treatment, whereas simply pushing through on willpower tends not to work and leads to dropout.
Completing a retraining programme over months or years requires sustained intrinsic motivation — the kind that gets someone back to the desk after a bad week — and that motivational architecture is partly dependent on dopamine and serotonin systems that oestrogen supports. Perimenopausal low mood, which is distinct from clinical depression but real and impairing, tends to erode the future orientation and reward anticipation that make long-term academic goals feel worth pursuing. Women who dropout of courses during this phase often describe it as losing the sense that it mattered, which maps closely onto the neurochemical profile of oestrogen-related mood disruption.
The single most practically useful piece of information for a perimenopausal woman in education is that most of these symptoms — brain fog, sleep disruption, hot flushes, anxiety, and fatigue — are either self-limiting as the hormonal transition completes or are responsive to treatment including HRT, which has good evidence for improving cognitive symptoms and sleep quality during perimenopause. Dropping out of a retraining programme because symptoms feel unmanageable is a decision that deserves to be made with full information, not in the fog of the transition itself. Seeking a GP review, discussing HRT, or even formally disclosing a health condition to an academic institution for reasonable adjustments can change outcomes — and women should know that these are legitimate and available options.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.